Syntara Limited (ASX:SNT) Expands Skin Scarring Program with SNT-9465
Syntara Limited (ASX:SNT) expands its skin scarring program with the new SNT-9465 drug, initiating Phase 1a/b trials in 2025.
Syntara Limited (ASX:SNT) expands its skin scarring program with the new SNT-9465 drug, initiating Phase 1a/b trials in 2025.
Volt Resources Limited (ASX:VRC) announces temporary executive remuneration adjustments and restructures its loan facility to enhance financial resilience.
Chimeric Therapeutics Limited (ASX:CHM) announces a $3.2 million entitlement offer to fund its ongoing cell therapy clinical trials.
Nanoveu Limited (ASX:NVU) completes acquisition of EMASS Semiconductor, enhancing its AI-driven edge computing capabilities.
Norwood Systems Ltd (ASX:NOR) signs a $2.98 million, five-year contract with Optus to replace their voicemail system with the CogVoice platform.
KGL Resources (ASX:KGL) reports final results from its 2024 drilling program, showcasing significant copper intersections and resource expansions across the Jervois Project.
AXP Energy Limited (ASX:AXP) partners with BitFuFu to expand gas-to-power operations, targeting 25MW by CY2025 for bitcoin mining growth.
AVITA Medical (ASX:AVH) partners with Stedical Scientific to enhance production and distribution of PermeaDerm wound matrix.
Navigator Global Investments Limited (ASX:NGI) acquires a 23.5% stake in healthcare investment firm 1315 Capital.
Global Health Limited (ASX:GLH) secures a $1 million contract with Youturn to enhance digital solutions for youth mental health services.